Clinical Trials Logo
  1. Home
  2. Nasal Congestion
  3. NCT02100605

Study on Hypertonic Saline Nasal Spray — PhytosunDecon  

Nasal Congestion Clinical Trial

Official title:
A Study to Assess the Speed of Relief From Nasal Congestion With a Hypertonic Saline Nasal Spray (Phytosun Decongestant)

Clinical Trial Summary

Phytosun decongestant nasal spray is a class I medical device registered in the European Union for the treatment of nasal congestion. The spray contains hypertonic seawater and essential oils. The objective of the study is to investigate the effects of a nasal spray, registered as a medical device under the name Phytosun Decongestant in the European Union, on speed of onset of relief of nasal congestion in 50 subjects suffering from nasal congestion associated with common cold.

Clinical Trial Description

The study will also include an exploratory assessement of any objective changes in nasal patency by measuring nasal peak inspiratory flow before and after treatment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02100605
Study type Interventional
Source Omega Pharma
Contact
Status Completed
Phase N/A
Start date March 2014
Completion date October 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT00665977 - Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure Phase 3
Completed NCT05843071 - PMCF Study to Evaluate Performance and Safety of "NASAL SPRAYS " Used to Relieve Nasal Congestion and Dryness N/A
Completed NCT00957996 - Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Phase 3
Completed NCT00829634 - Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation N/A
Completed NCT00662337 - Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride Phase 1
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Recruiting NCT05244148 - Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects N/A
Completed NCT05159271 - Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults N/A
Completed NCT02113449 - Market Potential of Carbon Dioxide Nasal Spray Phase 2
Terminated NCT00958776 - A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Phase 3
Completed NCT00648973 - To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Phase 4
Completed NCT03399721 - Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis N/A
Completed NCT01354418 - Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED) Phase 1
Completed NCT04797936 - BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 Phase 4
Completed NCT03906968 - The Safety and Efficacy of a SinuSonic Intervention N/A
Recruiting NCT06323304 - Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis N/A
Withdrawn NCT04790487 - Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis Phase 2/Phase 3
Completed NCT01448057 - Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu Phase 3
Completed NCT01129765 - Home Usability of a Nasal Lavage System in Children N/A
Completed NCT04910139 - A User Study of the Soniflow System for Nasal Congestion Relief N/A